Bonus Biogroup (BONS) - Total Liabilities

Latest as of December 2025: ILA21.11 Million ILA ≈ $56.58K USD

Based on the latest financial reports, Bonus Biogroup (BONS) has total liabilities worth ILA21.11 Million ILA (≈ $56.58K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BONS long-term investments to assets to see how much of total assets are deployed in long-term investments.

Bonus Biogroup - Total Liabilities Trend (2008–2025)

This chart illustrates how Bonus Biogroup's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see BONS total asset value.

Bonus Biogroup Competitors by Total Liabilities

The table below lists competitors of Bonus Biogroup ranked by their total liabilities.

Company	Country	Total Liabilities
Cingulate Inc NASDAQ:CING	USA	$12.56 Million
Eugene SPAC 1 KQ:187790	Korea	₩64.11 Billion
Pungguk Ethanol Industrial Co. Ltd KQ:023900	Korea	₩30.60 Billion
Gozco Plantations Tbk JK:GZCO	Indonesia	Rp898.23 Billion
Company K Partners Limited KQ:307930	Korea	₩8.74 Billion
Tex Cycle Technology M Bhd KLSE:0089	Malaysia	RM93.04 Million
Thantawan Industry Public Company Limited BK:THIP	Thailand	฿1.55 Billion
Cedergrenska AB ST:CEDER	Sweden	Skr312.40 Million

Liability Composition Analysis (2008–2025)

This chart breaks down Bonus Biogroup's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See BONS net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.13	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-3.73	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.37	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bonus Biogroup's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bonus Biogroup (2008–2025)

The table below shows the annual total liabilities of Bonus Biogroup from 2008 to 2025.

Year	Total Liabilities	Change
2025-12-31	ILA21.11 Million ≈ $56.58K	+28.31%
2024-12-31	ILA16.45 Million ≈ $44.10K	+5.55%
2023-12-31	ILA15.58 Million ≈ $41.78K	-14.47%
2022-12-31	ILA18.22 Million ≈ $48.85K	-8.40%
2021-12-31	ILA19.89 Million ≈ $53.33K	-4.15%
2020-12-31	ILA20.75 Million ≈ $55.64K	+0.20%
2019-12-31	ILA20.71 Million ≈ $55.53K	+55.31%
2018-12-31	ILA13.34 Million ≈ $35.75K	+11.49%
2017-12-31	ILA11.96 Million ≈ $32.07K	+16.59%
2016-12-31	ILA10.26 Million ≈ $27.50K	+43.58%
2015-12-31	ILA7.14 Million ≈ $19.16K	+82.32%
2014-12-31	ILA3.92 Million ≈ $10.51K	+128.91%
2013-12-31	ILA1.71 Million ≈ $4.59K	+23.97%
2012-12-31	ILA1.38 Million ≈ $3.70K	+54.99%
2011-12-31	ILA891.00K ≈ $2.39K	-97.99%
2010-12-31	ILA44.26 Million ≈ $118.67K	-24.68%
2009-12-31	ILA58.77 Million ≈ $157.56K	+50.91%
2008-12-31	ILA38.94 Million ≈ $104.40K	--

About Bonus Biogroup

TA:BONS Israel Biotechnology

Market Cap

$62.31 Million

ILA23.24 Billion ILA

Market Cap Rank

#21128 Global

#278 in Israel

Share Price

ILA19.90

Change (1 day)

+13.07%

52-Week Range

ILA17.20 - ILA58.50

All Time High

ILA171.00